Dermatol. praxi. 2016;10(4):201-202 | DOI: 10.36290/der.2016.045

B-lymfom dolních končetin, chemoterapie, anti-CD20, radioterapie.

MUDr. Eliška Langerová
FN u sv. Anny a LF MU v Brně

Cutaneous B-cell lymphomas There are 3 main types of cutaneous B-cell lymphomas: primary cutaneous marginal zone B- cell lymphoma, primary cutanous follicular center B-cell lymphoma and cutaneous diffuse large B-cell lymphoma, leg type. First two types are quite benign with mean 5-years survival of 95–99%, on the other hand and cutaneous diffuse large B-cell lymphoma, leg type is more agressive with mean 5-years survival rate of 55%. Therapy of cutaneous B-cell lymphoma is multidisciplinary in cooperation with hematooncologists ( chemotherapy, anti-CD20) and radion oncologists (radiotherapy- direct, total surface).

Keywords: primary cutaneous marginal zone B-cell lymphoma, primary cutanous follicular center B-cell lymphoma, cutaneous

Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Langerová E. B-lymfom dolních končetin, chemoterapie, anti-CD20, radioterapie. Dermatol. praxi. 2016;10(4):201-202. doi: 10.36290/der.2016.045.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Willemze R, Jaffe ES, et al. WHO-EORTC classification for cutaneous lymphomas; Blood 2005; 105(10): 3768-3785. Go to original source... Go to PubMed...
    2. LeBoit PE, et al. WHO Classification of Tumours: Skin Tumours; IARC Press, Lyon 2000: 165-199.
    3. Machovcová A. Kožní lymfomy; Czechopress agency, Praha 2009: 3-18 (reprint)
    4. Kempf W. Cutaneous B-Cell Lymphoma; dostupný z: medscape.org: 4/2013.
    5. Kempf W, Sander ChA. Classifiaction of cutaneous lymphomas - an update; Histopathology 2010; 56(1): 57-70. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.